Introduction
Epilepsy is a common devastating neurological condition. Although 80% of epileptic patients are seizure-free with rational anti-epileptic drug (AED) therapy, approximately 20% of patients with epilepsy have a medically intractable condition even when treated with various AEDs at maximal dosages, either alone or in combination. 1 Such epilepsy cases are, thus, referred to as intractable epilepsy (IE). Recurrent seizures may cause necrosis within certain cell populations. 2, 3 Studies have also identified upregulation of bcl-2 family genes, including Bcl-2, Bcl-XL and activated caspase 3 in temporal neocortices from patients with temporal lobe epilepsy (TLE). 4, 5 Therefore, the bcl-2 and caspase families, which regulate cell death, may play a role in ongoing neuropathologic processes in human epilepsy. 6 Further, more recent works have shown that increased Bax expression and activated caspases contribute to neuronal loss through apoptosis. 7 Calpains, a class of Ca 2+ -activated cysteine proteases, are major mediators for Ca 2+ signals in many biological systems. There are two subtypes of calpains: I or m-calpain and II or m-calpain; mcalpain is the predominant type found in tissues, including neocortex. 8 Calpains are proposed to participate in the turnover of cytoskeletal proteins and regulate kinases, cytokine,transcription factors and receptors.
found to be calpain substrates, such as caspase 3, caspase 9, Bax, and Bcl-xL. 10 Moreover, activated calpain mediates the degradation of calpain substrates in the course of neuronal death and contributes to the pathophysiology of neurological disorders, such as ischemia, trauma, Alzheimer's disease and demyelination. [11] [12] [13] [14] Bi et al. (1997) first reported the effect of calpain activation in animal models of epilepsy and, essentially, found a high degree of calpain expression. 15 Further evidence for increased calpain activity has been described in the hippocampus of rodent models of temporal lobe epilepsy. 16 Later, Araujo et al. investigated the activation of calpains and caspases in degenerating areas of the hippocampus, as well as the proteolysis of known substrates [spectrin, for calpains, and poly-ADP ribose polymerase (PARP) for caspase 3] in the hippocampus of rats given kainic acid (KA) systemically. They found that early calpain activation, but not caspase activation, is involved in neurotoxicity in the hippocampus after status epilepticus; calpain inhibition was strongly correlated with neurodegeneration in the hippocampus following seizures. 16 Calpain-mediated mechanisms may be responsible for seizure offset, probably through AMPA glutamate receptor internalization and further degradation. 17 Little information, however, is currently available concerning the role of calpains in intractable epilepsy.
Therefore, we investigated the expression of m-calpain in patients with intractable epilepsy and its correlation with clinicopathological characteristics.
Materials and methods

Patients selection
Intractable seizures were defined as those not controlled in all patients by maximal tolerated doses of at least two AEDs, including phenytoin, valproic acid, carbamazepine, phenobarbital, topiramate, oxcarbazepine, clonazepam, gabapentin and lamotrigine. A total of 30 patients with intractable epilepsy were recruited from the files of the department of neurosurgery of the following hospitals: The First Affiliated Hospital of Chongqing Medical University and Xinqiao Hospital of the Third Military Medical University. All of these patients underwent resection of the anterior temporal lobe. The diagnosis of epilepsy was determined according to the 1981 International Classification of Epileptic Seizures by the International League Against Epilepsy. Prior to surgery, the lesion was localized in all patients via several methods, including brain magnetic resonance imaging, a 24-h electroencephalogram or video electroencephalogram, sphenoidal electrode monitoring, and intraoperative electrocorticography. Table 1 summarizes the clinical features of the patients.
The control group consisted of temporal lobe samples obtained from 10 patients who underwent neurosurgical intervention due to brain trauma in the Neurosurgical Department of The First Affiliated Hospital of Chongqing Medical University. All controls were diagnosed as brain trauma, and neuropathologists found no abnormality in the specimen slides of these control patients. Table  2 shows the clinical features of the controls.
The study was approved by the ethics committee on human research at Chongqing Medical University. Informed consent was obtained from the patients or their relatives for the use of any data and tissues for research, which was performed in accordance with the Helsinki Declaration.
RT-PCR
cDNA equivalent to 20 ng of total RNA was subjected to subsequent semi-quantified PCR analysis using the following primers: CAPN1 (sense, TCG TGC TCG CCC TTA TGC; antisense, CTT GTC CAG GTC AAA CTT CC), and GAPDH (sense, ATC TGG CAC CAC ACC TTC TAC A; anti-sense, GTT TGG TGG ATG CCA CAG GAC T). In preliminary experiments, optimal cycling conditions were established for amplification of each cDNA. PCR products were separated on 1.5% agarose gel containing 10 g/ml ethidium bromide, photographed using the UVsolo system (Whatman Biometra) and densitometric analysis was performed with the BioDocAnalyze software (Whatman Biometra). Results were calculated according to levels of target mRNAs in relation to those of the housekeeping gene, GAPDH (three samples from each group were analyzed by PCR).
Western blotting
Tissues were homogenized and lysed in Laemmli buffer. The protein concentration of the lysates was determined using a Coomassie blue G-250 kit (Sigma, St. Louis, USA). The protein extracts (50 mg) were resolved by 10% SDS polyacrylamide gel electrophoresis and electrotransferred to a polyvinylidene difluoride (PVDF) membrane (Dupont,Wilmington, USA). The membranes were blocked with 3% BSA (Sigma) and then incubated for 2 h at room temperature in PBS. After extensive washing with phosphate buffered saline (PBS), the membranes were incubated with the following primary antibodies: rabbit anti-human m-calpain (1:200; Santa Cruz Biotechnology), 145 kDa a-spectrin specific antibody (1:200; Santa Cruz Biotechnology), and monoclonal anti-GAPDH (Santa Cruz Biotechnology) at a dilution of 1:1000 for 1 h. Goat antirabbit HPRIgG (1:5000; Sigma) was used for detection. Subsequently, the protein bands were visualized after exposure to film and the pixel density of the scanned film images was quantified using Labworks Analysis Software (UVP, Upland, USA). Western blot data were normalized relative to the density of the GAPDH bands.
Cytokine quantification
The overall cytokine levels in the anterior temporal lobe were measured by the Multi-Analyte ELISA array Kit (SA Biosciences, Frederick, MD, USA). Protein homogenates were extracted from the anterior temporal lobe using the Halt Protease Inhibitor Cocktail Kit (Pierce), centrifuged at 78,500 Â g for one 1 h at 4 8C, and were collected and stored at -70 8C until assayed. According to the kit's manual instructions, the levels of 12 cytokines and chemokines (IL1b, IL-6, IL-10, IL-12, IL-17a, IFN-g, TNF-a and TGF-b1) were detected simultaneously at 1:20 dilutions. Negative and positive controls supplied by the kits were also included. The reactions were analyzed at a wavelength of 450 nm using a 96-well microplate reader, Model 680 (Bio-Rad, Hercules, CA, USA).
Hematoxylin-eosin
The resected brain tissue was immediatedly fixed in 10% buffered formalin. After fixation in formalin for 48 h, the paraffinembedded tissue was sectioned into 10 mm slices for immunohistochemistry and immunofluorescence analysis, and then mounted onto polylysine-coated slides. One section of each specimen was processed for hematoxylin-eosin staining. Control samples were prepared in the same way. Surgical specimens, sectioned with a microtome and stained with hematoxylin-eosin, were submitted for neuropathological evalution..
Immunohistochemistry
The procedure was performed according to the manufacturer's protocol. First, paraffin sections were deparaffinized, hydrated through a graded ethanol series and incubated in 0.3% H 2 O 2 for 15 min. The sections were heated in a microwave oven for 10 min at 98 8C in citrate buffer (pH 6) for antigen retrieval, and blocked in normal goat serum (1:10; Zhongshan Golden Bridge Inc, Beijing, China) for 10 min. The sections were incubated in the following primary antibodies: primary rabbit anti-human m-calpain (1:150; Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at 37 8C, primary rabbit anti-human GFAP (1:200; Zhong shan Golden Bridge Inc, China). Anti-rabbit secondary antibody was used for detection for 30 min at 37 8C. Immunoreactivity was observed with 3,30-diaminobenzidine (Zhongshan Golden Bridge Inc.). The OLYMPUS PM20 automatic microscope (Olympus, Osaka, Japan) and TC-FY-2050 pathology system (Yuancheng Inc., Beijing, China) were used to collect the images. Primary antibodies were replaced with PBS (pH 7.2) and served as negative controls.
Immunofluorescence
Sections were deparaffinized and antigen was recovered as described in the previous section. Tissues were permeabilized with 0.5% (v/v) Triton X-100. After blocking with 10% goat serum in PBS for 30 min, followed by incubation with the following primary antibodies: rabbit anti-human m-calpain equipped with a Fluoview FVX confocal scanhead. The optical densities for every sample were analyzed automatically and semiquantitatively using the Motic Med 6.0 CMIAS pathology image analysis system (Beihang Motic, Inc., Beijing, China).
Statistical analysis
Data are represented as means AE standard error of the mean (SEM). Student's t-test was used for statistical analysis with SPSS 11.0 between epileptic tissues and the control tissues. p Value of <0.05 was used as the minimum criteria for statistical significance.
Results
Demographic and clinical characteristics of the epilepsy subjects
The mean age of the epilepsy patients was 24.06 AE 9.42 years, with 16 men and 14 women in the experimental group. The mean duration of seizure recurrence was 8.93 AE 4.06 years. The control group consisted of 10 men and 9 women, with an average age of 24.90 AE 8.65 years. Statistical analysis showed that there were no significant differences in age or sex between the IE patients and controls (p > 0.05). 50% of patients had neuronal loss while 86.7% had experienced seizure recurrence for at least 5 years, with 43.3% having recurrences for more than 10 years.
m-Calpain was overexpressed in the anterior temporal neocortex of patients with intractable epilepsy
The m-calpain gene was analyzed in epileptic tissues and control tissues using semi-quantification of RT-PCR products. The expression of the m-calpain gene in the control group was significantly lower compared to the epilepsy group (Fig. 1A) . calpain and a calpain-cleaved spectrin fragment of 145 kDa was observed in the epileptic tissues, whereas faintly stained bands were present in the control group samples (Fig. 1B) . m-Calpain expression was normalized by calculating the ratio of the optical density of the bands for m-calpain and GAPDH. The optical density ratio was 0.5146 AE 0.131 for epileptic tissues and 0.2756 AE 0. 0.070 for control tissues; these values were significantly different (p < 0.05). Analysis of the calpain-cleaved 145 kDa spectrin fragment expression in the control and the temporal lobe of IE patients by Western blotting indicated that relatively strong expression of 145 kDa a-spectrin was observed in the epileptic tissues, whereas faintly stained bands were present in the control group samples. The optical density ratio was 0.4746 AE 0.080 for epileptic tissues and 0.2056 AE 0.0467 for control tissues; these values were significantly different (p < 0.05).
Immunohistochemical study of m-calpain expression and localization in normal tissues and intractable epilepsy
Prominent m-calpain staining in the anterior temporal neocortex of patients with IE correlates with positive expression of mcalpain (buffy particles in the cytoplasm of neurons and glial cells), and was observed in the temporal lobe cortices in both IE patients and the control group using immunohistochemistry and immunofluorescence staining ( Fig. 2A and B) . Positive staining for mcalpain in this section is brown. There was significantly stronger m-calpain staining in epileptic temporal lobe tissues compared to control. The mean optical densities for the IE group and control group were 0.4124 AE 0.039 and 0.2521 AE 0.042, respectively. There was significantly higher expression of m-calpain in the temporal lobe cortex of the IE group compared to the control group (p < 0.05).
Immunofluorescence shows positive staining for m-calpain in this section as green. There was significantly stronger m-calpain staining in epileptic temporal lobe tissues compared to control. The mean optical densities for the IE group and control group were 0.8236 AE 0.102 and 0.4046 AE 0.0910, respectively. There was significantly higher expression of m-calpain in the temporal lobe cortex of the IE group compared to the control group (p <0.05).
GFAP was overexpressed in the cell cytoplasm of glial cells in patients with intractable epilepsy
Prominent GFAP staining in the anterior temporal neocortex of patients with IE correlates with positive expression of GFAP (buffy particles in the cytoplasm of glial cells), and was observed in the temporal lobe cortices in both IE patients and the control group using immunohistochemistry and immunofluorescence staining (Fig. 3) . Positive staining for GFAP in this section is brown. The mean optical densities for the IE group and control group were 0.5482 AE 0.042 and 0.3942 AE 0.038, respectively. There was significantly higher expression of GFAP in the temporal lobe cortex of the IE group compared to the control group (p < 0.05). Immunofluorescence staining shows positive staining for GFAP in this section as red. The mean optical densities for the IE group and control group were 0.7338 AE 0.0972 and 0.5923 AE 0.0945, respectively. There was significantly higher expression of GFAP in the temporal lobe cortex of the IE group compared to the control group (p < 0.05).
3.5. IL-1b, IL-6 and TGF-b1 were upregulated in patients with intractable epilepsy There were no differences in protein homogenates levels of IL-10, IL-12, IL-17a, IFN-g, TNF-a levels between the study groups. Protein homogenates levels of IL-1b, IL-6 and TGF-b1 were higher and statistically significant in the IE group than in control group (Fig. 4) .
Clinicopathological characteristics of the anterior temporal lobe in intractable epilepsy
Temporal lobe tissues taken from the control group and from patients with intractable epilepsy were sliced into 10 mm sections using a microtome and stained with hematoxylin-eosin. We found the following four types of pathological changes: neuronal loss, neuronal degeneration, gliosis and astrocytosis. Fig. 5B , D, and F are representative of specimens showing neuronal loss, neuronal degeneration and gliosis. These findings are consistent with previous studies of intractable epilepsy revealing neuronal degeneration and necrosis. [18] [19] [20] 
Discussion
Since seizures can lead to the impairment of neurons, it can be surmised that the most important finding in the pathophysiology of intractable epilepsy is apoptosis and necrosis of neurons 21 .
Previous studies have reported that neuronal loss existed in patients with epilepsy, especially in those with recurrent or status epilepsy [18] [19] [20] . In our study, we found the following pathological changes: neuron loss, neuronal degeneration, gliosis and astrocytosis. Neuron loss and neuronal degeneration are two, distinct separate features. Neuronal degeneration is due to hypoxia and hypoperfusion, but can be reversed if hypoxia and hypoperfusion are improved. However, neuron loss occurs as a result of deterioration of neuronal degeneration, and the injured neuron is swallowed by microglia. Gliosis and astrocytosis have been confirmed by overexpression of GFAP. Our study results show that 50% of patients had neuronal loss; therefore, we inferred that neuronal loss, a hallmark of neurodegenerative diseases, plays an important pathogenic role in the progression of IE.
To our knowledge, this is the first time the expression of mcalpain in the anterior temporal neocortex of patients with IE has been reported. In our study, we found that the level of m-calpain and the 145 kDa SBDP corresponds to m-calpain-mediated cleavage expression in IE brain tissues were up-regulated phenomenally.
m-calpain, the main subtype of the calpain family which was found in the central nervous system by Guroff more than 50 years ago, 22 was required in concentrations of 2-80 mM Ca 2+ for halfmaximal activity. The process of m-calpain activation occurs by an established progression of events beginning with calcium binding to the EF-hand structures. Once bound, m-calpain becomes autocatalytic, cleaving itself on both large and small subunits, and leaving truncated N-terminals of 76 and 18 kDa, respectively. 23 Thus, this process could catalyze the proteolysis involved in cytoskeletal remodeling, cytokine, cell-cycle regulation, signal transduction, cell differentiation, embryonic development and vesicular trafficking. 24, 25 However, pathological overactivation of [ ( ) T D $ F I G ] Fig. 4 . The levels of IL-1b, IL-6 and TGF-b1 were increased in IE patients. Protein homogenates were extracted from the anterior temporal lobe and the levels of IL1b, IL-6 and TGF-b1 were detected simultaneously at 1:20 dilutions. The concentrations of IL-1b and TGF-b1 in epileptic tissues were significantly greater compared to controls (p < 0.05). The concentration of IL-6 in epileptic tissues was especially significant (p < 0.01). The data are expressed as mean AE SD, and the value of *p < 0.05, **p < 0.01 is indicated as significantly different.
m-calpain mediates abnormal degradation of many proteins and, eventually, causes cell death. 26 Spectrin is widely distributed throughout the cytoplasm and is easily accessible for cleavage by different proteases, giving rise to stable spectrin breakdown products (SBDPs) that can be identied by immunostaining. It is now known that m-calpain-mediated breakdown of aII-spectrin creates several aII-spectrin breakdown products (SBDPs). Caspase-3-mediated cleavage creates 150 and 120 kDa SBDPs, whereas m-calpain creates 150 and 145 SBDPs. In this study, the cleavage product of m-calpain (including the 150 kDa and 145 kDa spectrin) and the cleavage product of caspase 3 (including the 150 kDa and 120 kDa spectrin) were regulated by m-calpain. Therefore, this study selected 145 kDa SBDP, instead of 150 kDa, as a marker of increased m-calpain expression. The 145 kDa SBDP corresponds to m-calpain-mediated cleavage was found to be increased in the patient specimens.
The previous study by Araujo et al. 16 had shown that seizures lead to calpain activation and proteolysis of spectrin in the hippocampus as a result of KA injection. This clinical finding shows that temporal neocortex from intractable epilepsy patients express raised levels of Bcl-2, Bcl-XL and activated caspase 3. 6 Moreover, during focal cerebral ischemia-reperfusion, m-calpain is an upstream regulator of caspase 3, 27 and has been suggested to be involved in apoptosis by activating caspase-3 in IE.
Certainly, m-calpain can also injure neurons by other pathways.m-calpain could regulate cytokines. [28] [29] [30] While cytokines are associated with pathological changes in intractable epilepsy. 31, 32 This clinical finding shows that marked activation of microglia and astrocytes and diffuse cell death were observed in epileptogenic tissue. IL-1beta, IL-8, IL-12p70 and MIP-1beta were significantly increased in the epileptogenic cortex. IL-6 and MCP-1 were significantly higher in patients with family history of epilepsy. 31 Their results suggest that active neuroinflammation and marked cellular injury occur in pediatric epilepsy and may play a common pathogenic role or consequences in childhood epilepsy of diverse etiologies. In our study, we found that upregulated expression of IL-1b, IL-6 and TGF-b1 belongs to inflammation markers. Therefore, we theorized that m-calpain can cause these pathological results through inflammation. However, several issues need to be considered when interpreting the results of this study. Firstly, because of the practical difficulty in obtaining normal human brain specimens, we had to use structurally normal brain tissue obtained from temporal lobectomies performed for the treatment of traumatic brain injuries as controls. We made a preliminary evaluation of the control tissues by Western blot analysis to determine whether expression of m-calpain in brain trauma specimens were accordant. The results show that there is no difference in the expression of m-calpain among the five control anterior temporal neocortex samples which were collected. Recent studies have shown that structurally normal brain tissue obtained from traumatic brain injury can be used as controls. 33, 34 Secondly, m-calpain's involvement in the pathological process leading to causative or consequential epileptic seizures remains unclear. Based on the potential effects of m-calpain on neuronal apoptosis, we hypothesize that its upregulation may play an important pathogenic role in the progression of IE. However, due to the limitations of the human study, the abovementioned hypothesis should be further investigated in animal models and in vitro experiments.
In conclusion, m-calpain is upregulated in the anterior temporal neocortex of patients with IE, which may correlate with pathological changes in these regions. The biological significance of overexpression of m-calpain warrants further investigation.
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